Australia's Genetic Technologies hits record high on launch of cancer test

Genetic Technologies

03/02/2023 03:15

** Shares of Genetic Technologies Ltd  GTG.AX  soar as much
as 166.7% to A$0.008, hitting a record high
    ** Molecular diagnostics company says it will launch a
simple saliva test which evaluates women's risk of developing
breast and/or ovarian cancer 
    ** Adds the cancer could be result from a hereditary genetic
mutation or from the far more common familial or sporadic cancer
    ** Says the test will be launched via co's business to
business and consumer initiated testing channels in the United
States
    ** Stock hits highest level since Oct 21, 2021
    ** More than 246.8 mln shares change hands, almost 100 times
the 30-day average volume 
 (Reporting by Poonam Behura in Bengaluru)
 ((Poonam.Behura@thomsonreuters.com;))